QV BIOELECTRONICS LTD.

Active United Kingdom

Manufacture of irradiation, electromedical and electrotherapeutic equipment

11 employees website.com
Life sciences and medical technology Manufacture of irradiation, electromedical and electrotherapeutic equipmentResearch and experimental development on biotechnology
Q

QV BIOELECTRONICS LTD.

Manufacture of irradiation, electromedical and electrotherapeutic equipment

Founded 7 Oct 2018 Active United Kingdom 11 employees website.com
Life sciences and medical technology Manufacture of irradiation, electromedical and electrotherapeutic equipmentResearch and experimental development on biotechnology

Previous Company Names

HONEYCOMB BIOTECHNOLOGY LIMITED 7 Oct 2018 — 4 Sept 2019
Accounts Due 30 Sept 2026 3 months remaining
Confirmation Submitted 20 May 2026 Next due 6 Apr 2027 10 months remaining
Net assets £519K £728K 2024 year on year
Total assets £689K £818K 2024 year on year
Total Liabilities £171K £90K 2024 year on year
Charges 2
1 outstanding 1 satisfied

Contact & Details

Contact

Email

info@example.com

Website

www.example.com

Full company profile for QV BIOELECTRONICS LTD. (11608210), an active life sciences and medical technology company based in United Kingdom. Incorporated 7 Oct 2018. Manufacture of irradiation, electromedical and electrotherapeutic equipment. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type total-exemption-full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2019–2024)

Cash in Bank

£97.12k

Decreased by £816.60k (-89%)

Net Assets

£518.58k

Decreased by £727.68k (-58%)

Total Liabilities

£170.82k

Decreased by £89.95k (-34%)

Turnover

N/A

Employees

11

Decreased by 2 (-15%)

Debt Ratio

25%

Increased by 8 (+47%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 4
Grants 4

Investors (8)

Investor NameInvestor SinceParticipating Rounds
Investor 2Jul 2021Venture - Series Unknown, Seed
Investor 8Jul 2021Seed
Investor 9Jul 2021Seed

Share Capital

Share Capital

Share allotments and capital structure

19 Allotments 3,479,750 Shares £5.58m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
9 Dec 2025222,218£1.62£1.62
9 Dec 2025613,166£993k£1.62
12 Sept 2025130,362£203k£1.555
12 Sept 2025307,393£478k£1.555
12 Sept 2025130,362£203k£1.555

Officers

Officers

2 active 1 resigned
Status
Fink, Alexander MichaelDirectorBritishUnited Kingdom3910 Dec 2025Active
Horncastle, MarkDirectorBritishEngland5310 Dec 2025Active

Shareholders

Shareholders (34)

Christopher Bullock
21.7%
600,000
Richard Zhiming Fu
14.4%
400,000

Persons with Significant Control

Persons with Significant Control (0)

0 Active 2 Ceased

Christopher John Bullock

Ceased 23 Dec 2022

Ceased

Richard Zhiming Fu

Ceased 30 Jun 2021

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

1 outstanding 1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
20 May 2026Confirmation StatementConfirmation statement made on 23 Mar 2026 with updates
14 May 2026CapitalAllotment of shares (GBP 41.03713) on 2 Apr 2026
30 Apr 2026MiscellaneousReplacement filing of SH01 - 12/09/25 Statement of Capital gbp 32.06601
9 Jan 2026IncorporationMemorandum Articles
9 Jan 2026ResolutionResolutions
20 May 2026 Confirmation Statement

Confirmation statement made on 23 Mar 2026 with updates

14 May 2026 Capital

Allotment of shares (GBP 41.03713) on 2 Apr 2026

30 Apr 2026 Miscellaneous

Replacement filing of SH01 - 12/09/25 Statement of Capital gbp 32.06601

9 Jan 2026 Incorporation

Memorandum Articles

9 Jan 2026 Resolution

Resolutions

Recent Activity

Latest Activity

Confirmation statement made on 23 Mar 2026 with updates

2 weeks ago on 20 May 2026

Allotment of shares (GBP 41.03713) on 2 Apr 2026

3 weeks ago on 14 May 2026

Replacement filing of SH01 - 12/09/25 Statement of Capital gbp 32.06601

1 months ago on 30 Apr 2026

Memorandum Articles

4 months ago on 9 Jan 2026

Resolutions

4 months ago on 9 Jan 2026